Pages
Derbyshire health and care system remains under pressure; patients continue to be asked to not store up care needs
Update as of 17:00hrs - 22 December 2022
Industrial Action Update - Issued on 16 January 2023
Ahead of this week’s planned industrial action by the Royal College of Nursing (RCN), we’ve developed an in-depth briefing which we hope colleagues will find useful. It also signposts to other helpful sources of information.
https://dchs.nhs.uk/my_dchs/show-me/staff-news-my-download/industrial-action-update-16-january
Keep up to date with innovations and emerging research to improve your practice
introducing KnowledgeShare - an online web-based current awareness system being offered by Derbyshire NHS Library and Knowledge Service.
Wellbeing support across Joined Up Care Derbyshire - New Spring activity timetable for 2023 is here!
Files
Overgranulation Treatment Pathway (G262)
G262 - Overgranulation Treatment Pathway
DFHS 0-19 service presentation
DFHS 0-19 service presentation
UTC Procedures for Mass Casualties and Contaminated Self-Presenters Plan
DCHS UTC Procedures for Mass Casualties and Contaminated Self-Presenters Plan
A5 - Constipation Pathway (P91)
A5 - Constipation Pathway
DCHS Scheme Of Delegation
Scheme Of Delegation - April 2025
A2 - Catheter Clinical Appointment Letter (G324)
Catheter Clinical Appointment Letter
Disclosure Ref 2024131 - Cyber Security Attacks.pdf
FOI Disclosure Ref 2024131 relating to Cyber Security Attacks
Disclosure Ref 2024128 - Social Media Platforms.pdf
FOI Disclosure Ref 2024128 - Social Media Platforms
Disclosure Ref 2024134 - Trust Policy for Scope of Nursing Associates.pdf
Disclosure Ref 2024134 - Trust Policy for Scope of Nursing Associates
INR Testing procedure within Derbyshire Community Health Services by Podiatry Surgery at Ilkeston and Buxton Hospitals (S128)
Only podiatric surgery with the relevant equipment, training and framework in place will be able to utilise this procedure. This clinical procedure will support clinical staff in practice to include arrangements with regards the procedure of the taking of the INR test, quality assurance /quality control, Control of Substances Hazardous to Health (COSHH) assessment, Infection control measures, and any relevant Health and Safety issues. In line with recommendations within the Medicines and Healthcare Products Regulatory Agency (MHRA) Device Bulletin “Management and use of In Vitro Diagnostic (IVD) Point of Care Test Devices DB 2010(02) February 2010